Manufacturer: Hugel Pharma
Active Substance(s): BOTULINUM TOXIN TYPE A
Strength: 200u
Pack Size: 1 x 200u Vial (Powder)
BOTULAX® is a peripheral muscle relaxant that contains purified botulinum toxin type A (in combination with haemagglutinin) and sodium chloride (excipient). The mechanism of action of the product is based on the ability of botulinum toxin type A to block the transmission of nerve impulses. Intramuscular administration of the toxin disrupts the synthesis of acetylcholine (a neurotransmitter that ensures neuromuscular conduction) and leads to temporary paralysis of the facial muscles. Frozen facial expressions help relax muscles and smooth wrinkles.Anti-wrinkle treatment to be used for nasolabial folds, hyperhidrosis, lip contouring, and overall natural face lifting
INFORMATION
BOTULAX® 200u (Korean) Key Features and Benefits
BOTULAX® 200u (Korean) is a botulinum toxin type A product used for aesthetic and therapeutic purposes. It provides reliable quality, reasonable pricing, and tailored services. Produced by Hugel Pharma, the product meets high standards of quality and stability.
- High Stability: Stabilized potency with strict quality control.
- Cost-Effectiveness: Provides excellent value for its efficacy.
- Custom Development: Involves input from aesthetic field professionals.
- Widespread Use: Registered in multiple countries, including Korea, Thailand, and Chile.
BOTULAX® 200u (Korean) Reconstitution Chart
The product requires proper reconstitution with 0.9% sodium chloride solution before administration. This ensures accurate dosing and optimal efficacy.
- Dilution Guidelines:
- Use sterile saline without preservatives.
- Gently inject the saline into the vial to avoid foaming.
- Recommended Volumes:
- For 200 units: Refer to the dilution chart in the manual for the precise amount based on the required dose.
BOTULAX® 200u (Korean) Storage Information
Proper storage is critical to maintain the product’s potency and safety. BOTULAX® 200u must be stored in specific conditions.
- Temperature: Store at 2–8°C in a hermetically sealed container.
- Shelf Life: 24 months from the manufacturing date.
- Post-Reconstitution: Use within 24 hours and store at 2–8°C.
BOTULAX® 200u (Korean) Treatment Areas
BOTULAX® 200u is indicated for use in various aesthetic and therapeutic areas, ensuring targeted and effective treatment.
- Common Treatment Areas:
- Facial wrinkles (e.g., glabellar lines).
- Muscle hyperactivity conditions.
- Blepharospasm and other muscle disorders.
BOTULAX® 200u (Korean) Dosing for Different Indications
The dosing varies based on the treatment indication. Each dose must be customized to the patient’s condition and treatment area.
- General Guidelines:
- Initial dose: 1.25–2.5 units per site for glabellar lines.
- Blepharospasm: 1.25–2.5 units injected into the medial and lateral pre-tarsal orbicularis oculi muscles.
- Frequency: Treatments can be repeated every 3 months.
BOTULAX® 200u (Korean) Side Effects and Precautions
While generally safe, BOTULAX® 200u may cause side effects in some patients. Adherence to guidelines minimizes risks.
- Common Side Effects:
- Localized pain or bruising at the injection site.
- Temporary muscle weakness or drooping.
- Rare Side Effects:
- Dysphagia, breathing difficulties, or systemic reactions.
- Precautions:
- Avoid in patients with neuromuscular disorders or known hypersensitivity.
- Not recommended during pregnancy or breastfeeding.
BOTULAX® 200u (Korean) Aftercare
Proper aftercare enhances treatment outcomes and minimizes complications.
- Immediate Care:
- Avoid touching or massaging the treated area for 24 hours.
- Refrain from strenuous physical activities and lying down for 4 hours post-treatment.
- Long-Term Care:
- Follow-up sessions may be scheduled every 3–4 months.
BOTULAX® 200u (Korean) Drug Interactions
Understanding potential drug interactions ensures safe administration of BOTULAX® 200u.
- Avoid Concomitant Use With:
- Aminoglycosides (e.g., gentamicin) and other agents that affect neuromuscular transmission.
- Muscle relaxants and anticoagulants.
- Combination Therapies: Consult with a medical professional to assess compatibility.
BOTULAX® 200u (Korean) Clinical Evidence
Clinical trials have demonstrated the efficacy and safety of BOTULAX® 200u compared to other botulinum toxin products.
- Key Findings:
- Comparable efficacy to Botox® in treating blepharospasm.
- No severe adverse drug reactions in trials.
- Patient Satisfaction:
- High satisfaction rates due to consistent results and low complication rates.
BOTULAX® 200u (Korean) Regulatory and Safety Information
BOTULAX® 200u complies with stringent regulatory requirements to ensure safety and efficacy.
- Manufacturer: Hugel Pharma, South Korea.
- Certifications: Meets KFDA standards and international requirements.
- Packaging: Supplied in 200-unit vials with detailed labeling.
BOTULAX® 200u (Korean) Key Features and Benefits
BOTULAX® 200u (Korean) is a botulinum toxin type A product used for aesthetic and therapeutic purposes. It provides reliable quality, reasonable pricing, and tailored services. Produced by Hugel Pharma, the product meets high standards of quality and stability.
- High Stability: Stabilized potency with strict quality control.
- Cost-Effectiveness: Provides excellent value for its efficacy.
- Custom Development: Involves input from aesthetic field professionals.
- Widespread Use: Registered in multiple countries, including Korea, Thailand, and Chile.
BOTULAX® 200u (Korean) Reconstitution Chart
The product requires proper reconstitution with 0.9% sodium chloride solution before administration. This ensures accurate dosing and optimal efficacy.
- Dilution Guidelines:
- Use sterile saline without preservatives.
- Gently inject the saline into the vial to avoid foaming.
- Recommended Volumes:
- For 200 units: Refer to the dilution chart in the manual for the precise amount based on the required dose.
BOTULAX® 200u (Korean) Storage Information
Proper storage is critical to maintain the product’s potency and safety. BOTULAX® 200u must be stored in specific conditions.
- Temperature: Store at 2–8°C in a hermetically sealed container.
- Shelf Life: 24 months from the manufacturing date.
- Post-Reconstitution: Use within 24 hours and store at 2–8°C.
BOTULAX® 200u (Korean) Treatment Areas
BOTULAX® 200u is indicated for use in various aesthetic and therapeutic areas, ensuring targeted and effective treatment.
- Common Treatment Areas:
- Facial wrinkles (e.g., glabellar lines).
- Muscle hyperactivity conditions.
- Blepharospasm and other muscle disorders.
BOTULAX® 200u (Korean) Dosing for Different Indications
The dosing varies based on the treatment indication. Each dose must be customized to the patient’s condition and treatment area.
- General Guidelines:
- Initial dose: 1.25–2.5 units per site for glabellar lines.
- Blepharospasm: 1.25–2.5 units injected into the medial and lateral pre-tarsal orbicularis oculi muscles.
- Frequency: Treatments can be repeated every 3 months.
BOTULAX® 200u (Korean) Side Effects and Precautions
While generally safe, BOTULAX® 200u may cause side effects in some patients. Adherence to guidelines minimizes risks.
- Common Side Effects:
- Localized pain or bruising at the injection site.
- Temporary muscle weakness or drooping.
- Rare Side Effects:
- Dysphagia, breathing difficulties, or systemic reactions.
- Precautions:
- Avoid in patients with neuromuscular disorders or known hypersensitivity.
- Not recommended during pregnancy or breastfeeding.
BOTULAX® 200u (Korean) Aftercare
Proper aftercare enhances treatment outcomes and minimizes complications.
- Immediate Care:
- Avoid touching or massaging the treated area for 24 hours.
- Refrain from strenuous physical activities and lying down for 4 hours post-treatment.
- Long-Term Care:
- Follow-up sessions may be scheduled every 3–4 months.
BOTULAX® 200u (Korean) Drug Interactions
Understanding potential drug interactions ensures safe administration of BOTULAX® 200u.
- Avoid Concomitant Use With:
- Aminoglycosides (e.g., gentamicin) and other agents that affect neuromuscular transmission.
- Muscle relaxants and anticoagulants.
- Combination Therapies: Consult with a medical professional to assess compatibility.
BOTULAX® 200u (Korean) Clinical Evidence
Clinical trials have demonstrated the efficacy and safety of BOTULAX® 200u compared to other botulinum toxin products.
- Key Findings:
- Comparable efficacy to Botox® in treating blepharospasm.
- No severe adverse drug reactions in trials.
- Patient Satisfaction:
- High satisfaction rates due to consistent results and low complication rates.
BOTULAX® 200u (Korean) Regulatory and Safety Information
BOTULAX® 200u complies with stringent regulatory requirements to ensure safety and efficacy.
- Manufacturer: Hugel Pharma, South Korea.
- Certifications: Meets KFDA standards and international requirements.
- Packaging: Supplied in 200-unit vials with detailed labeling.
Related products
